{
  "nctId": "NCT04309110",
  "briefTitle": "Efficacy of Adhesive Strength of New Hydrogel Formulation",
  "officialTitle": "Evaluation of the Adhesive Strength of the Geko™ X-T3 Neuromuscular Stimulator Incorporating a New Skin Adhesive Hydrogel Formulation Designated KM40C",
  "protocolDocument": {
    "nctId": "NCT04309110",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-09-29",
    "uploadDate": "2023-04-13T07:32",
    "size": 1421521,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04309110/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NON_RANDOMIZED",
  "interventionModel": "SEQUENTIAL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 40,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2021-07-13",
    "completionDate": "2021-11-25",
    "primaryCompletionDate": "2021-11-25",
    "firstSubmitDate": "2020-03-12",
    "firstPostDate": "2020-03-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Male or female aged ≥ 18 years\n* Currently an in-patient hospitalised for acute stroke\n* Use of geko™ as a mechanical prophylaxis strategy for venous thromboembolism\n* Patient understands and is willing to participate in the study and is able to comply with study procedures\n\nExclusion Criteria:\n\n* Pregnancy or breast feeding\n* Use of any neuro-modulation device other than geko™\n* Participation in any other clinical study that may interfere with the outcome of either study",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Efficacy of the Skin Adhesive Strength of Hydrogel KM40C Compared to That of Hydrogel KM10T.",
        "description": "Self reported - how well did the geko™ device stick to the patients leg? Scale 1-5, Lowest score indicates best adhesion.",
        "timeFrame": "10 days"
      }
    ],
    "secondary": [
      {
        "measure": "Incidence of Adverse Events",
        "description": "Reporting of the incidence of adverse events , incidence of serious adverse events, incidence of study treatment related adverse events, and the incidence of device related adverse events",
        "timeFrame": "10 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SEQUENTIAL"
    },
    "overallComplexityScore": 19,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:36.885Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}